China Traditional Chinese Medicine Holdings Co. Limited
China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CHIZF · as of 2026-06-08
Financial statements
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $14.36B | $16.51B | $18.12B | $14.30B | $19.05B |
| Cost of Revenue | $7.46B | $8.65B | $8.85B | $7.11B | $7.22B |
| Gross Profit | $6.91B | $7.86B | $9.27B | $7.20B | $11.83B |
| Gross Margin %(computed) | 48.09% | 47.59% | 51.18% | 50.32% | 62.09% |
| Operating Expenses | |||||
| R&D Expenses | $0.50B | $0.60B | $0.69B | $0.61B | $0.69B |
| G&A Expenses | $0.00B | $1.06B | $1.04B | $0.94B | $0.97B |
| Total Operating Expenses | $6.61B | $7.52B | $7.85B | $6.13B | $9.12B |
| Operating Income | $0.30B | $0.34B | $1.43B | $1.06B | $2.75B |
| Operating Margin %(computed) | 2.07% | 2.03% | 7.88% | 7.44% | 14.45% |
| Interest Income | $0.03B | $0.05B | $0.07B | $0.07B | $0.06B |
| Interest Expense | $0.10B | $0.24B | $0.20B | $0.22B | $0.22B |
| Income Before Tax | ($0.36B) | $0.16B | $1.22B | $0.84B | $2.52B |
| Income Tax Expense | $0.09B | $0.14B | ($0.17B) | $0.12B | $0.40B |
| Net Income | ($0.33B) | $0.05B | $1.29B | $0.76B | $1.93B |
| Net Margin %(computed) | -2.32% | 0.33% | 7.09% | 5.34% | 10.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $0.01 | $0.26 | $0.15 | $0.38 |
| Wtd Avg Shares | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B |
| EBITDA | $1.40B | $1.53B | $2.56B | $2.16B | $3.59B |
| EBITDA Margin %(computed) | 9.74% | 9.26% | 14.11% | 15.10% | 18.85% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CNY · B
Explore more China Traditional Chinese Medicine Holdings Co. Limited data
About China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) Income Statement
China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CHIZF reported revenue of $14.36B, gross profit of $6.91B (gross margin 48.09%), and net income of ($0.33B) — a net profit margin of -2.32%.
Frequently asked questions
CHIZF · 4 questionsChina Traditional Chinese Medicine Holdings Co. Limited (CHIZF) reported revenue of $14.36B for 2025, down 13.0% year-over-year.
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08